Total planned funding: $258,005,057
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Mozambique | $68,570,376 |
| Zambia | $41,045,161 |
| South Africa | $18,925,016 |
| Tanzania | $17,589,411 |
| India | $9,414,357 |
| Kenya | $9,099,896 |
| Nigeria | $9,080,493 |
| Burundi | $8,881,413 |
| Indonesia | $8,357,229 |
| Cambodia | $6,725,000 |
| Haiti | $6,576,452 |
| Rwanda | $5,586,437 |
| Côte d'Ivoire | $5,530,736 |
| Vietnam | $5,380,374 |
| Zimbabwe | $4,344,201 |
| South Sudan | $3,996,962 |
| Asia Regional Program | $3,400,093 |
| Democratic Republic of the Congo | $3,390,975 |
| Ethiopia | $3,257,708 |
| Malawi | $3,101,446 |
| Caribbean Region | $2,525,420 |
| Papua New Guinea | $2,486,306 |
| Angola | $2,466,719 |
| Eswatini | $2,047,187 |
| Botswana | $1,840,003 |
| Uganda | $1,795,686 |
| Ghana | $1,290,000 |
| China | $850,000 |
| Dominican Republic | $250,000 |
| Thailand | $200,000 |
| Central Asia Region | $0 |
Organizational Types
| NGO | $250,353,620 |
| Implementing Agency | $7,651,437 |
Program Areas
| Prevention | $75,234,029 |
| Care | $73,100,996 |
| Treatment | $60,234,828 |
| Testing | $27,239,816 |
| Governance and Systems | $22,195,388 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $53,090,336 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $45,615,493 |
| HKID: Care: Orphans and Vulnerable Children | $40,036,029 |
| HVCT: Testing: HIV Testing and Counseling | $27,239,816 |
| HBHC: Care: Adult Care and Support | $20,134,246 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $13,308,225 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,282,301 |
| HVSI: Strategic Information | $8,659,070 |
| OHSS: Health Systems Strengthening | $7,964,744 |
| PDTX: Treatment: Pediatric Treatment | $7,144,492 |
| PDCS: Care: Pediatric Care and Support | $6,771,725 |
| HVTB: Care: TB/HIV | $6,158,996 |
| HLAB: Laboratory Infrastructure | $5,571,574 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,947,428 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $1,542,969 |
| HMBL: Biomedical Prevention: Blood Safety | $334,929 |
| HMIN: Biomedical Prevention: Injection Safety | $202,684 |
| HTXD: Treatment: ARV Drugs | $0 |